Auxly Cannabis Group Stock Fundamentals
XLY Stock | CAD 0.04 0 7.14% |
Auxly Cannabis Group fundamentals help investors to digest information that contributes to Auxly Cannabis' financial success or failures. It also enables traders to predict the movement of Auxly Stock. The fundamental analysis module provides a way to measure Auxly Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auxly Cannabis stock.
At this time, Auxly Cannabis' Depreciation And Amortization is very stable compared to the past year. As of the 28th of November 2024, Interest Expense is likely to grow to about 26.9 M, though Gross Profit is likely to grow to (1.8 M). Auxly | Select Account or Indicator |
Auxly Cannabis Group Company Shares Outstanding Analysis
Auxly Cannabis' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Auxly Cannabis Shares Outstanding | 1.25 B |
Most of Auxly Cannabis' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Auxly Cannabis Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Auxly Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Auxly Cannabis is extremely important. It helps to project a fair market value of Auxly Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Auxly Cannabis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Auxly Cannabis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Auxly Cannabis' interrelated accounts and indicators.
Click cells to compare fundamentals
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Auxly Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Auxly Cannabis Group has 1.25 B of shares currently outstending. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all Canada stocks is 119.15% lower than that of the firm.
Auxly Cannabis Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Auxly Cannabis's current stock value. Our valuation model uses many indicators to compare Auxly Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Auxly Cannabis competition to find correlations between indicators driving Auxly Cannabis's intrinsic value. More Info.Auxly Cannabis Group is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers . At this time, Auxly Cannabis' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Auxly Cannabis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Auxly Cannabis' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Auxly Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Auxly Cannabis' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Auxly Cannabis could also be used in its relative valuation, which is a method of valuing Auxly Cannabis by comparing valuation metrics of similar companies.Auxly Cannabis is currently under evaluation in shares outstanding category among its peers.
Auxly Cannabis Current Valuation Drivers
We derive many important indicators used in calculating different scores of Auxly Cannabis from analyzing Auxly Cannabis' financial statements. These drivers represent accounts that assess Auxly Cannabis' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Auxly Cannabis' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 322.1M | 161.0M | 144.9M | 17.8M | 9.9M | 9.4M | |
Enterprise Value | 377.7M | 264.5M | 320.3M | 196.8M | 153.3M | 80.5M |
Auxly Fundamentals
Return On Equity | -0.52 | ||||
Return On Asset | -0.0309 | ||||
Profit Margin | (0.41) % | ||||
Operating Margin | 0.17 % | ||||
Current Valuation | 96.4 M | ||||
Shares Outstanding | 1.25 B | ||||
Shares Owned By Insiders | 21.73 % | ||||
Shares Owned By Institutions | 0.24 % | ||||
Number Of Shares Shorted | 348.01 K | ||||
Price To Book | 0.39 X | ||||
Price To Sales | 0.41 X | ||||
Revenue | 101.08 M | ||||
Gross Profit | 19.29 M | ||||
EBITDA | (30.95 M) | ||||
Net Income | (44.51 M) | ||||
Cash And Equivalents | 14.64 M | ||||
Cash Per Share | 0.02 X | ||||
Total Debt | 159.04 M | ||||
Debt To Equity | 1.20 % | ||||
Current Ratio | 2.58 X | ||||
Book Value Per Share | 0.05 X | ||||
Cash Flow From Operations | 8.21 M | ||||
Short Ratio | 0.88 X | ||||
Earnings Per Share | (0.07) X | ||||
Target Price | 0.02 | ||||
Number Of Employees | 369 | ||||
Beta | 1.22 | ||||
Market Capitalization | 44.93 M | ||||
Total Asset | 261.9 M | ||||
Retained Earnings | (483.27 M) | ||||
Working Capital | (38.98 M) | ||||
Net Asset | 261.9 M |
About Auxly Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Auxly Cannabis Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Auxly Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Auxly Cannabis Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for Next Year | ||
Current Deferred Revenue | 0.90 | 0.86 | |
Total Revenue | 101.1 M | 106.1 M | |
Cost Of Revenue | 103 M | 108.1 M | |
Stock Based Compensation To Revenue | 0.02 | 0.02 | |
Sales General And Administrative To Revenue | 0.39 | 0.37 | |
Capex To Revenue | 0.02 | 0.02 | |
Revenue Per Share | 0.10 | 0.10 | |
Ebit Per Revenue | (0.19) | (0.20) |
Other Information on Investing in Auxly Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.